Edoardo Cignoli : New Cancer Drugs Offer Hope---at Steep Cost

The first of a promising new class of cancer drugs went on sale in Japan this week at an average annual cost of $143,000 a patient, a harbinger of hefty prices the new drugs are expected to command in the U.S. and Europe.



via WSJ.com: US Business http://ift.tt/1BcpnjI